Opinion

Video

The Role of Bone-Targeted Therapies

Paul E. Dato, MD, discusses how bone-targeted therapies play an important supportive role in advanced prostate cancer, with recommendations for calcium and vitamin D supplementation, vitamin K2 consideration, resistance exercises, and regular monitoring for all patients on ADT.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Clinical Brief: Bone-Targeted Therapies in Advanced Prostate Cancer

      Main Discussion Topics

      • Therapeutic Goals: Prevention of skeletal-related events and protection of bone health during androgen deprivation therapy (ADT)
      • Evidence Base: Limited guideline support for denosumab in hormone-sensitive disease vs established role in castration-resistant setting
      • Zoledronic Acid: Recent STAMPEDE trial data showing reduced fracture risk, though not yet incorporated into guidelines
      • Supportive Measures: Calcium and vitamin D supplementation, resistance exercise, and bone density monitoring

      Key Points for Physicians

      • All patients on ADT should receive calcium and vitamin D3 supplementation
      • Vitamin K2 may help activate proteins binding calcium to bones (contraindicated with anticoagulants)
      • Resistance exercises should be recommended as physical condition permits
      • Regular monitoring of bone density, calcium levels, and renal function is essential

      Notable Insights

      While denosumab and zoledronic acid have established roles in castration-resistant disease, emerging evidence suggests potential benefits in hormone-sensitive settings that may influence future guideline recommendations.

      Clinical Significance

      Comprehensive bone health management is an essential component of prostate cancer care, requiring attention to both pharmacologic interventions and supportive measures to reduce fracture risk and maintain quality of life.

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      © 2025 MJH Life Sciences

      All rights reserved.